NEXUS

📅 Upcoming

🕒 Recent(90d)

News

• FDA Launches New Program to Advance Neuroscience Medical Product Development
  FDA announces the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s efforts to accelerate medical innovation and deliv…
  fda_press · 12d ago
• Iambic CEO on taking an AI drug company public
  Fresh off a $150 million IPO, Tom Miller spoke to BioPharma Dive about the roadshow process and how he sees AI’s role in drug development evolving.
  biopharma_dive · 18d ago
• Iambic, an AI drug discovery specialist, banks $150M in an IPO
  Part of a wave of young biotechs employing AI to accelerate research, the company claimed in regulatory filings that its approach has the potential to “disrupt legacy drug discovery paradigms.”
  biopharma_dive · 20d ago
• Opinion: We think a baby’s gut microbiome could be key to lifelong brain health
  “We need more rigorous, large-scale research into the gut-brain axis across the life course,” write Holly Baines and George Vradenburg.
  stat · 20d ago
• A Parkinson's biotech debut, fundraising campaign and licensing deal
  Plus news about Altis Labs, Matisse Pharmaceuticals, AstraZeneca, Novo, Longeveron, Connexus Therapeutics and Avacta. A new Parkinson’s biotech: The Michael J. Fox Foundation is supporting a non-ha…
  endpoints · 1mo ago
• Opinion: 3 lessons from the tobacco settlement on how states should use money from Meta
  “Whether it’s nicotine or algorithms, the result is the same: reinforcing a behavior that is harmful to users,” writes Susan Morrisey.
  stat · 1mo ago
• FTC sues Hims & Hers over alleged privacy violations, deceptive billing practices
  Regulators say the telehealth company illegally shared patients’ health data with advertisers and misled its customers. Hims & Hers hit back, calling the claims “baseless.”
  biopharma_dive · 3mo ago
• FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
  The FDA has approved Freenome’s new blood-based colorectal cancer test, SimpleScreen CRC, which Abbott will exclusively market in the U.S.
  fiercebiotech · 3mo ago
• Nancy Cox, a CDC veteran and a stalwart in global flu research, dies at 77
  Nancy Cox, a CDC veteran who for decades was a global leader in influenza research, has died at 77.
  stat · 6mo ago
• Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series A
  The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
  fiercebiotech · 10mo ago